- Home
- EDBL vs CYCC Comparison
EDBL vs CYCC Comparison
Compare EDBL & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDBL
- CYCC
- Stock Information
- Founded
- EDBL 2020
- CYCC 1992
- Country
- EDBL United States
- CYCC Malaysia
- Employees
- EDBL N/A
- CYCC N/A
- Industry
- EDBL Farming/Seeds/Milling
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- EDBL Consumer Staples
- CYCC Health Care
- Exchange
- EDBL Nasdaq
- CYCC Nasdaq
- Market Cap
- EDBL 7.2M
- CYCC 7.8M
- IPO Year
- EDBL 2022
- CYCC N/A
- Fundamental
- Price
- EDBL $2.61
- CYCC $16.04
- Analyst Decision
- EDBL
- CYCC
- Analyst Count
- EDBL 0
- CYCC 0
- Target Price
- EDBL N/A
- CYCC N/A
- AVG Volume (30 Days)
- EDBL 127.1K
- CYCC 5.3M
- Earning Date
- EDBL 08-13-2025
- CYCC 08-13-2025
- Dividend Yield
- EDBL N/A
- CYCC N/A
- EPS Growth
- EDBL N/A
- CYCC N/A
- EPS
- EDBL N/A
- CYCC N/A
- Revenue
- EDBL $13,443,000.00
- CYCC $14,000.00
- Revenue This Year
- EDBL $29.56
- CYCC $137.21
- Revenue Next Year
- EDBL $20.00
- CYCC N/A
- P/E Ratio
- EDBL N/A
- CYCC N/A
- Revenue Growth
- EDBL N/A
- CYCC N/A
- 52 Week Low
- EDBL $1.80
- CYCC $3.08
- 52 Week High
- EDBL $39.50
- CYCC $597.60
- Technical
- Relative Strength Index (RSI)
- EDBL 45.87
- CYCC 60.33
- Support Level
- EDBL $2.54
- CYCC $10.05
- Resistance Level
- EDBL $2.76
- CYCC $19.87
- Average True Range (ATR)
- EDBL 0.13
- CYCC 3.57
- MACD
- EDBL 0.01
- CYCC 1.99
- Stochastic Oscillator
- EDBL 54.05
- CYCC 77.07
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.